Related Experiment Video
Updated: Nov 20, 2025

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
Published on: September 26, 2025
General Purpose Structure-Based Drug Discovery Neural Network Score Functions with Human-Interpretable Pharmacophore
Benjamin P Brown1, Jeffrey Mendenhall2, Alexander R Geanes2
1Chemical and Physical Biology Program, Medical Scientist Training Program, Center for Structural Biology, Vanderbilt University, Nashville, Tennessee 37232, United States.
The BioChemical Library (BCL) now includes structure-based virtual screening tools, enhancing drug discovery. New neural network scoring functions, BCL-AffinityNet and BCL-DockANNScore, show top performance in predicting molecular binding affinity and aiding optimization.
Area of Science:
- Computational chemistry
- Cheminformatics
- Drug discovery
Background:
- The BioChemical Library (BCL) is an open-source cheminformatics toolkit.
- Existing BCL tools focus on ligand-based virtual high-throughput screening (vHTS).
Purpose of the Study:
- To expand the BCL capabilities to include structure-based virtual screening.
- To introduce novel scoring functions for protein-ligand interactions.
- To enhance small molecule discovery and design.
Main Methods:
- Developed two new neural network-based scoring functions: BCL-AffinityNet and BCL-DockANNScore.
- Utilized novel distance-dependent signed protein-ligand atomic property correlations.
- Trained models using feed-forward dropout neural networks.
Main Results:
- BCL-AffinityNet demonstrated top performance in affinity prediction and ranking tasks (CASF-2016).
- BCL-AffinityNet showed strong performance on CSAR-NRC HiQ I and II datasets.
- BCL-DockANNScore proved competitive with state-of-the-art methods in docking and screening power.
- Models were decomposable into interpretable pharmacophore maps.
Conclusions:
- The expanded BCL toolkit effectively supports structure-based virtual screening.
- New scoring functions significantly aid in small molecule discovery and lead optimization.
- BCL-AffinityNet and BCL-DockANNScore are valuable additions to computational drug design.
More Related Videos
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
10:21Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
Related Concept Videos
Drug Discovery: Overview
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Pharmacodynamics: Overview and Principles
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Quantitative Aspects of Drug-Receptor Interaction